Benzinga | Aug 6, 2020 10:04AM EDT

Evoke Pharma Q2 EPS $(0.28) Down From $(0.09) YoY

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.28) per share. This is a 211.11 percent decrease over losses of $(0.09) per share from the same period last year.